BY MARKETWIRE
-
Novo’s Catalent acquisition approved in Brazil
Novo Holdings’ purchase of agreement producer Catalent is still encountering installing resistance in the United States, nevertheless.
-
Lundbeck Foundation may sell or list Falck, media reports
If the sale or public providing turns into a actuality, Falck is predicted to be valued at round EUR 1.5bn.
-
GN aims to strengthen position VA sales as competition heats up
In September, the Danish firm had a 9.9% market share in regards to complete sales– below 10.2% in August, reveal the current information from VA.
-
Demant CEO sees power consumption as crucial parameter in development of AI hearing aids
AI systems can dramatically raise power intake, needing added initiative to maintain intake controlled.
-
Demant: VA growth continues to be held back by lack of capacity
Scarcity of team is at fault for the weak market development, claims Demant’s president.
-
Novo Nordisk opposes insulin choice in US price negotiations
The Danish drugmaker urges that the 6 various insulin therapies are not similar due to the fact that they have actually all undertaken different medical tests.
-
WSA: Apple’s move highlights hearing health, but market remains steady
WS Audiology monitoring invites Apple’s access right into the industry without seeing danger to well-known listening device producers.
-
Demant eyes growth in France next year with new reimbursement eligibility
The Danish business has a solid market placement in France, where, along with wholesale, it additionally has a huge share of the retail market adhering to the purchase of Audika ne…
-
Demant CEO sees power consumption as crucial parameter in development of AI hearing aids
AI systems can significantly increase power consumption, requiring extra effort to keep consumption under control.
-
Hearing aid manufacturers kick off annual industry trade show at the crest of growth wave
Albeit with considerable changes in private markets and sales networks, development has actually been greater than regular, particularly in late 2023 and throughout 2024.